By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test development firm Genetic Technologies said today it has completed a financing round that raised A$11.7 million (US$12.7 million).

The funds were raised through a private placement of 60 million new shares at A$.195 per share to institutional and private investors in Australia and the US. The offering was oversubscribed and 12 new institutional investors participated in the placement, Genetic Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.